Vanton Research Laboratory's Infusion Delivery System for an Oncologic NCE Will Proceed with IND
About Vanton
Vanton Research Laboratory, LLC is a privately owned contract research organization (CRO) and a specialty phama, focusing on development of non-conventional drug delivery systems. It provides a comprehensive range of fully integrated Pharmaceutical Development Services including pre-formulation, formulation, analytical development, and clinical manufacturing. In addition to CRO services, Vanton also develops in-house pipeline products for niche markets. The leading product is a subcutaneous Ropivacaine depot system using its proprietary molecular caging (MC) technology for post-operational pain management. Other specialty products focus on chronic disease treatment using its novel sustained released oral disintegrating tablet (ODT-SR) technology.
For more information about the company, please visit www.vantonlab.com
CONTACT:
Vanton Research Laboratory, LLC
Ms. Julie M. Chen
Chief Operating Officer
925-687-7814
Investor Relations: Ms. Carol Hafizi
carolhafizi@vantonlab.com